LAMEA Infectious Respiratory Disease Diagnostics Market Size, Share & Industry Trends Analysis Report By Product Type, By Application, By Sample Type, By Technology (Molecular Diagnostics, Microbiology, Immunoassay), By End-use, By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Infectious Respiratory Disease Diagnostics Market would witness market growth of -2.3% CAGR during the forecast period (2022-2028).

The modern approach of laboratory diagnosis for respiratory viral infections has evolved as molecular testing, which normally offers a quick turnaround time. The majority of respiratory pathogen molecular test findings are accessible in a few hours, with some platforms providing results in as little as one. A single specimen can now be tested for numerous infections because of the development of multiplexed panels from early molecular assays, which were initially created to target a single pathogen.

The respiratory targets selected differ greatly from manufacturer to manufacturer. There are single pathogen assays, mini panels that test a small number of targets, and comprehensive panels that test a large number of pathogens from a single material. Results are accessible considerably more quickly, but the convenience comes at a premium price. The cost of the assay reagents and/or reimbursement for the tests based on clinical presentation and diagnosis could be utilized to account for this.

Acute respiratory tract infections (RTIs) are becoming more common, and this causes significant mortality rates in both children and adults around the world. In the past few years, RTI caused a large number of deaths across all age categories, making it the third greatest cause of mortality worldwide, behind cardiovascular illnesses and neoplasms.

Large portions of the Middle East are desert. While it can be hot and humid in the summer, the temperature can drop significantly in the winter. Invulnerable people, especially asthmatics, may experience an aggravation of chronic lung diseases as a result of these weather changes. Although the prevalence of asthma in this region of the world has not been extensively described, it is thought to be high. As a result, the demand for infectious respiratory disease diagnostics would increase.

The Brazil market dominated the LAMEA Infectious Respiratory Disease Diagnostics Market by Country in 2021; thereby, achieving a market value of $719 million by 2028. The Argentina is poised to grow at a CAGR of -1.7% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of -2.5% during (2022 - 2028).

Based on Product Type, the market is segmented into Consumables, Instruments (Imaging Tests, Respiratory Measurement Devices, and Others), Services. Based on Application, the market is segmented into SARS/COVID 19, Influenza, RSV (Respiratory Syncytial Virus), Tuberculosis, Streptococcus Testing, and Others. Based on Sample Type, the market is segmented into Saliva, Anterior Nasal Region, Blood, Nasopharyngeal Swabs (NPS), and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Microbiology, Immunoassay, and Others. Based on End-use, the market is segmented into Diagnostic Laboratories, Hospitals, and Physician Offices & Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Infectious Respiratory Disease Diagnostics Market is Predict to reach $ 37.2 Billion by 2028, at a CAGR of -5.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Qiagen N.V., Bio-Rad Laboratories, Inc., Danaher Corporation, Quidel Corporation

Scope of the Study

Market Segments Covered in the Report:

By Product Type

• Consumables
• Instruments
  • Imaging Tests
  • Respiratory Measurement Devices
  • Others
• Services

By Application

• SARS/COVID 19
• Influenza
• RSV (Respiratory Syncytial Virus)
• Tuberculosis
• Streptococcus Testing
• Others

By Sample Type

• Saliva
• Anterior Nasal Region
• Blood
• Nasopharyngeal Swabs (NPS)
• Others

By Technology

• Molecular Diagnostics
• Microbiology
• Immunoassay
• Others

By End Use

• Diagnostic Laboratories
• Hospitals
• Physician Offices & Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Becton, Dickinson and Company
• Siemens Healthineers AG (Siemens AG)
• Thermo Fisher Scientific, Inc.
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Quidel Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Infectious Respiratory Disease Diagnostics Market, by Product Type
1.4.2 LAMEA Infectious Respiratory Disease Diagnostics Market, by Application
1.4.3 LAMEA Infectious Respiratory Disease Diagnostics Market, by Sample Type
1.4.4 LAMEA Infectious Respiratory Disease Diagnostics Market, by Technology
1.4.5 LAMEA Infectious Respiratory Disease Diagnostics Market, by End Use
1.4.6 LAMEA Infectious Respiratory Disease Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.2.5 Approval & Trails:
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Mar – 2022, Jun) Leading Players

Chapter 4. LAMEA Infectious Respiratory Disease Diagnostics Market by Product Type
4.1 LAMEA Consumables Market by Country
4.2 LAMEA Instruments Market by Country
4.3 LAMEA Infectious Respiratory Disease Diagnostics Market by Instruments Type
4.3.1 LAMEA Imaging Tests Market by Country
4.3.2 LAMEA Respiratory Measurement Devices Market by Country
4.3.3 LAMEA Others Market by Country
4.4 LAMEA Services Market by Country

Chapter 5. LAMEA Infectious Respiratory Disease Diagnostics Market by Application
5.1 LAMEA SARS/COVID 19 Market by Country
5.2 LAMEA Influenza Market by Country
5.3 LAMEA RSV (Respiratory Syncytial Virus) Market by Country
5.4 LAMEA Tuberculosis Market by Country
5.5 LAMEA Streptococcus Testing Market by Country
5.6 LAMEA Others Market by Country

Chapter 6. LAMEA Infectious Respiratory Disease Diagnostics Market by Sample Type
6.1 LAMEA Saliva Market by Country
6.2 LAMEA Anterior Nasal Region Market by Country
6.3 LAMEA Blood Market by Country
6.4 LAMEA Nasopharyngeal Swabs (NPS) Market by Country
6.5 LAMEA Others Market by Country

Chapter 7. LAMEA Infectious Respiratory Disease Diagnostics Market by Technology
7.1 LAMEA Molecular Diagnostics Market by Country
7.2 LAMEA Microbiology Market by Country
7.3 LAMEA Immunoassay Market by Country
7.4 LAMEA Others Market by Country

Chapter 8. LAMEA Infectious Respiratory Disease Diagnostics Market by End-use
8.1 LAMEA Diagnostic Laboratories Market by Country
8.2 LAMEA Hospitals Market by Country
8.3 LAMEA Physician Offices & Others Market by Country

Chapter 9. LAMEA Infectious Respiratory Disease Diagnostics Market by Country
9.1 Brazil Infectious Respiratory Disease Diagnostics Market
9.1.1 Brazil Infectious Respiratory Disease Diagnostics Market by Product Type
9.1.1.1 Brazil Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.1.2 Brazil Infectious Respiratory Disease Diagnostics Market by Application
9.1.3 Brazil Infectious Respiratory Disease Diagnostics Market by Sample Type
9.1.4 Brazil Infectious Respiratory Disease Diagnostics Market by Technology
9.1.5 Brazil Infectious Respiratory Disease Diagnostics Market by End-use
9.2 Argentina Infectious Respiratory Disease Diagnostics Market
9.2.1 Argentina Infectious Respiratory Disease Diagnostics Market by Product Type
9.2.1.1 Argentina Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.2.2 Argentina Infectious Respiratory Disease Diagnostics Market by Application
9.2.3 Argentina Infectious Respiratory Disease Diagnostics Market by Sample Type
9.2.4 Argentina Infectious Respiratory Disease Diagnostics Market by Technology
9.2.5 Argentina Infectious Respiratory Disease Diagnostics Market by End-use
9.3 UAE Infectious Respiratory Disease Diagnostics Market
9.3.1 UAE Infectious Respiratory Disease Diagnostics Market by Product Type
9.3.1.1 UAE Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.3.2 UAE Infectious Respiratory Disease Diagnostics Market by Application
9.3.3 UAE Infectious Respiratory Disease Diagnostics Market by Sample Type
9.3.4 UAE Infectious Respiratory Disease Diagnostics Market by Technology
9.3.5 UAE Infectious Respiratory Disease Diagnostics Market by End-use
9.4 Saudi Arabia Infectious Respiratory Disease Diagnostics Market
9.4.1 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Product Type
9.4.1.1 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.4.2 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Application
9.4.3 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Sample Type
9.4.4 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Technology
9.4.5 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by End-use
9.5 South Africa Infectious Respiratory Disease Diagnostics Market
9.5.1 South Africa Infectious Respiratory Disease Diagnostics Market by Product Type
9.5.1.1 South Africa Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.5.2 South Africa Infectious Respiratory Disease Diagnostics Market by Application
9.5.3 South Africa Infectious Respiratory Disease Diagnostics Market by Sample Type
9.5.4 South Africa Infectious Respiratory Disease Diagnostics Market by Technology
9.5.5 South Africa Infectious Respiratory Disease Diagnostics Market by End-use
9.6 Nigeria Infectious Respiratory Disease Diagnostics Market
9.6.1 Nigeria Infectious Respiratory Disease Diagnostics Market by Product Type
9.6.1.1 Nigeria Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.6.2 Nigeria Infectious Respiratory Disease Diagnostics Market by Application
9.6.3 Nigeria Infectious Respiratory Disease Diagnostics Market by Sample Type
9.6.4 Nigeria Infectious Respiratory Disease Diagnostics Market by Technology
9.6.5 Nigeria Infectious Respiratory Disease Diagnostics Market by End-use
9.7 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market
9.7.1 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Product Type
9.7.1.1 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.7.2 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Application
9.7.3 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Sample Type
9.7.4 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Technology
9.7.5 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by End-use

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Becton, Dickinson and Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Siemens Healthineers AG (Siemens AG)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisitions and Mergers:
10.3.5.3 Geographical Expansions:
10.3.6 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Product Launches and Product Expansions:
10.5 Koninklijke Philips N.V.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 F. Hoffmann-La Roche Ltd.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.7 Qiagen N.V.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Product Launches and Product Expansions:
10.8 Bio-Rad laboratories, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Product Launches and Product Expansions:
10.9 Danaher Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisitions and Mergers:
10.10. Quidel Corporation
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Approvals & Trails:

TABLE 1 LAMEA Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Infectious Respiratory Disease Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Infectious Respiratory Disease Diagnostics Market
TABLE 5 Acquisition and Mergers– Infectious Respiratory Disease Diagnostics Market
TABLE 6 Geographical Expansion– Infectious Respiratory Disease Diagnostics Market
TABLE 7 Approval & TRAILS – Infectious Respiratory Disease Diagnostics Market
TABLE 8 LAMEA Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 9 LAMEA Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 10 LAMEA Consumables Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Consumables Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 15 LAMEA Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 16 LAMEA Imaging Tests Market by Country, 2018 - 2021, USD Million
TABLE 17 LAMEA Imaging Tests Market by Country, 2022 - 2028, USD Million
TABLE 18 LAMEA Respiratory Measurement Devices Market by Country, 2018 - 2021, USD Million
TABLE 19 LAMEA Respiratory Measurement Devices Market by Country, 2022 - 2028, USD Million
TABLE 20 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 21 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 22 LAMEA Services Market by Country, 2018 - 2021, USD Million
TABLE 23 LAMEA Services Market by Country, 2022 - 2028, USD Million
TABLE 24 LAMEA Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 25 LAMEA Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 26 LAMEA SARS/COVID 19 Market by Country, 2018 - 2021, USD Million
TABLE 27 LAMEA SARS/COVID 19 Market by Country, 2022 - 2028, USD Million
TABLE 28 LAMEA Influenza Market by Country, 2018 - 2021, USD Million
TABLE 29 LAMEA Influenza Market by Country, 2022 - 2028, USD Million
TABLE 30 LAMEA RSV (Respiratory Syncytial Virus) Market by Country, 2018 - 2021, USD Million
TABLE 31 LAMEA RSV (Respiratory Syncytial Virus) Market by Country, 2022 - 2028, USD Million
TABLE 32 LAMEA Tuberculosis Market by Country, 2018 - 2021, USD Million
TABLE 33 LAMEA Tuberculosis Market by Country, 2022 - 2028, USD Million
TABLE 34 LAMEA Streptococcus Testing Market by Country, 2018 - 2021, USD Million
TABLE 35 LAMEA Streptococcus Testing Market by Country, 2022 - 2028, USD Million
TABLE 36 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 37 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 38 LAMEA Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 39 LAMEA Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 40 LAMEA Saliva Market by Country, 2018 - 2021, USD Million
TABLE 41 LAMEA Saliva Market by Country, 2022 - 2028, USD Million
TABLE 42 LAMEA Anterior Nasal Region Market by Country, 2018 - 2021, USD Million
TABLE 43 LAMEA Anterior Nasal Region Market by Country, 2022 - 2028, USD Million
TABLE 44 LAMEA Blood Market by Country, 2018 - 2021, USD Million
TABLE 45 LAMEA Blood Market by Country, 2022 - 2028, USD Million
TABLE 46 LAMEA Nasopharyngeal Swabs (NPS) Market by Country, 2018 - 2021, USD Million
TABLE 47 LAMEA Nasopharyngeal Swabs (NPS) Market by Country, 2022 - 2028, USD Million
TABLE 48 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 49 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 50 LAMEA Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 51 LAMEA Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 52 LAMEA Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 53 LAMEA Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 54 LAMEA Microbiology Market by Country, 2018 - 2021, USD Million
TABLE 55 LAMEA Microbiology Market by Country, 2022 - 2028, USD Million
TABLE 56 LAMEA Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 57 LAMEA Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 58 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 59 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 60 LAMEA Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 61 LAMEA Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 62 LAMEA Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 63 LAMEA Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 64 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 65 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 66 LAMEA Physician Offices & Others Market by Country, 2018 - 2021, USD Million
TABLE 67 LAMEA Physician Offices & Others Market by Country, 2022 - 2028, USD Million
TABLE 68 LAMEA Infectious Respiratory Disease Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 69 LAMEA Infectious Respiratory Disease Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 70 Brazil Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 71 Brazil Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 72 Brazil Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 73 Brazil Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 74 Brazil Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 75 Brazil Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 76 Brazil Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 77 Brazil Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 78 Brazil Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 79 Brazil Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 80 Brazil Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 81 Brazil Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 82 Brazil Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 83 Brazil Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 84 Argentina Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 85 Argentina Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 86 Argentina Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 87 Argentina Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 88 Argentina Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 89 Argentina Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 90 Argentina Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 91 Argentina Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 92 Argentina Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 93 Argentina Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 94 Argentina Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 95 Argentina Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 96 Argentina Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 97 Argentina Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 98 UAE Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 99 UAE Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 100 UAE Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 101 UAE Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 102 UAE Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 103 UAE Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 104 UAE Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 105 UAE Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 106 UAE Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 107 UAE Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 108 UAE Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 109 UAE Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 110 UAE Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 111 UAE Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 112 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 113 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 114 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 115 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 116 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 117 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 118 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 119 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 120 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 121 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 122 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 123 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 124 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 125 Saudi Arabia Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 126 South Africa Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 127 South Africa Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 128 South Africa Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 129 South Africa Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 130 South Africa Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 131 South Africa Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 132 South Africa Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 133 South Africa Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 134 South Africa Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 135 South Africa Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 136 South Africa Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 137 South Africa Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 138 South Africa Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 139 South Africa Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 140 Nigeria Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 141 Nigeria Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 142 Nigeria Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 143 Nigeria Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 144 Nigeria Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 145 Nigeria Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 146 Nigeria Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 147 Nigeria Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 148 Nigeria Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 149 Nigeria Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 150 Nigeria Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 151 Nigeria Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 152 Nigeria Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 153 Nigeria Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 154 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 155 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 156 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 157 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 158 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 159 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 160 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 161 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 162 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 163 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 164 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 165 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 166 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 167 Rest of LAMEA Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 168 Key Information – Abbott Laboratories
TABLE 169 Key information – Becton, Dickinson and Company
TABLE 170 Key Information – Siemens Healthineers AG
TABLE 171 Key Information – Thermo Fisher Scientific, Inc.
TABLE 172 Key Information – Koninklijke Philips N.V.
TABLE 173 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 174 Key Information – Qiagen N.V.
TABLE 175 Key Information – Bio-Rad Laboratories, Inc.
TABLE 176 Key Information – Danaher Corporation
TABLE 177 key information – Quidel Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2020, Mar – 2022, Jun) Leading Players
FIG 5 Recent strategies and developments: Abbott Laboratories
FIG 6 Swot analysis: Abbott laboratories
FIG 7 Recent strategies and developments: Becton, Dickinson and Company
FIG 8 Swot analysis: Becton, Dickinson and company
FIG 9 Recent strategies and developments: Siemens Healthineers AG
FIG 10 Swot analysis: Siemens AG
FIG 11 Recent strategies and developments: Thermo Fisher Scientific, Inc.